Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 16/20 | 0.66 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7796407 | 1.00 | SRD5A1 (0.66) | SRD5A1SRD5A2CYP2D6TSHRSLC6A2 | |
| SCHEMBL7798978 | 0.83 | SRD5A1 (0.80) | SRD5A1SRD5A2 | |
| SCHEMBL7798977 | 0.83 | SRD5A1 (0.80) | SRD5A1SRD5A2 | |
| SCHEMBL7789452 | 0.80 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL7799921 | 0.80 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL7789453 | 0.80 | SRD5A1 (1.00) | SRD5A1SRD5A2 | |
| SCHEMBL7799877 | 0.79 | SRD5A1 (0.60) | SRD5A1SRD5A2 | |
| SCHEMBL7799881 | 0.79 | SRD5A1 (0.60) | SRD5A1SRD5A2 | |
| SCHEMBL7796278 | 0.77 | SRD5A1 (0.71) | SRD5A1SRD5A2 | |
| SCHEMBL7796276 | 0.77 | SRD5A1 (0.71) | SRD5A1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0591583-B1 | Benzo (f) quinolinones as 5-alpha-reductase inhibitors | LILLY CO ELI (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-0532190-B1 | Benzo(f)quinolinones as 5-alpha-reductase inhibitors | LILLY CO ELI (US) | 2000-12-27 | — | — | EP | disclosed |
| US-5710163-A | STEROID 5A-REDUCTASE INHIBITORS | ELI LILLY AND COMPANY (US) | 1998-01-20 | — | — | US | disclosed |
| US-5670512-A | SKIN DISORDERS; REDUCTASE INHIBITORS | ELI LILLY AND COMPANY (US) | 1997-09-23 | — | — | US | disclosed |
| US-5541190-A | TREATING BENIGN PROSTATIC HYPERPLASIA, MALE PATTERN BALDNESS, PROSTATIC CANCER, ANDROGENIC ALOPECIA | ELI LILLY AND COMPANY (US) | 1996-07-30 | — | — | US | disclosed |
| US-5495021-A | STEROID 5 ALPHA-REDUCTASE INHIBITORS | ELI LILLY AND COMPANY (US) | 1996-02-27 | — | — | US | disclosed |
| US-5334767-A | Steroid 5a-reductase inhibitor | ELI LILLY AND COMPANY (US) | 1994-08-02 | — | — | US | disclosed |
| EP-0591583-A1 | Benzo (f) quinolinones as 5-alpha-reductase inhibitors | ELI LILLY AND COMPANY (US) | 1994-04-13 | — | — | EP | disclosed |
| US-5239075-A | PROCESS FOR THE PREPARATION OF BENZO (F) QUINOLINONES | ELI LILLY AND COMPANY (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0532190-A2 | Benzo f quinolinones as 5-alpha-reductase inhibitors | ELI LILLY AND COMPANY (US) | 1993-03-17 | — | — | EP | disclosed |